These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of Organs From Hepatitis C Virus-Positive Donors for Uninfected Recipients: A Potential Cost-Effective Approach to Save Lives? Trotter PB; Summers DM; Ushiro-Lumb I; Robb M; Bradley JA; Powell J; Watson CJE; Neuberger J Transplantation; 2018 Apr; 102(4):664-672. PubMed ID: 29166338 [TBL] [Abstract][Full Text] [Related]
3. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus). Natov SN Transpl Infect Dis; 2002 Sep; 4(3):124-31. PubMed ID: 12421456 [TBL] [Abstract][Full Text] [Related]
4. Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy. Bowring MG; Kucirka LM; Massie AB; Ishaque T; Bae S; Shaffer AA; Garonzik Wang J; Sulkowski M; Desai N; Segev DL; Durand CM Transplantation; 2018 Dec; 102(12):2088-2095. PubMed ID: 29912046 [TBL] [Abstract][Full Text] [Related]
5. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes. Pruett TL; Clark MA; Taranto SE Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients. Kadatz M; Klarenbach S; Gill J; Gill JS Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402 [TBL] [Abstract][Full Text] [Related]
7. Organ Donors with Human Immunodeficiency Virus and Hepatitis C Virus: Expanding the Donor Pool. Salas J; Storm K; Durand CM Infect Dis Clin North Am; 2023 Sep; 37(3):641-658. PubMed ID: 37258326 [TBL] [Abstract][Full Text] [Related]
8. Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney. Shelton BA; Sawinski D; Mehta S; Reed RD; MacLennan PA; Locke JE Transpl Infect Dis; 2018 Apr; 20(2):e12829. PubMed ID: 29277956 [TBL] [Abstract][Full Text] [Related]
9. Listing practices and graft utilization of hepatitis C-positive deceased donors in liver and kidney transplant. Kling CE; Perkins JD; Biggins SW; Johnson CK; Limaye AP; Sibulesky L Surgery; 2019 Jul; 166(1):102-108. PubMed ID: 31072671 [TBL] [Abstract][Full Text] [Related]
10. Impact of donor hepatitis C virus infection status on death and need for liver transplant in hepatitis C virus-positive kidney transplant recipients. Kucirka LM; Peters TG; Segev DL Am J Kidney Dis; 2012 Jul; 60(1):112-20. PubMed ID: 22560841 [TBL] [Abstract][Full Text] [Related]
11. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study. Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524 [TBL] [Abstract][Full Text] [Related]
12. Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices. Theodoropoulos N; Ladner DP; Ison MG Transpl Infect Dis; 2013 Oct; 15(5):545-9. PubMed ID: 23901896 [TBL] [Abstract][Full Text] [Related]
13. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation. Seem DL; Lee I; Umscheid CA; Kuehnert MJ Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284 [TBL] [Abstract][Full Text] [Related]
14. Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial. Reese PP; Abt PL; Blumberg EA; Van Deerlin VM; Bloom RD; Potluri VS; Levine M; Porrett P; Sawinski D; Nazarian SM; Naji A; Hasz R; Suplee L; Trofe-Clark J; Sicilia A; McCauley M; Gentile C; Smith J; Niknam BA; Bleicher M; Reddy KR; Goldberg DS Ann Intern Med; 2018 Sep; 169(5):273-281. PubMed ID: 30083748 [TBL] [Abstract][Full Text] [Related]
15. Use of Hepatitis C Positive Organs: Patient Attitudes in Urban Chicago. Couri T; Cotter TG; Chen D; Hammes M; Reddy B; Josephson M; Yeh H; Chung RT; Paul S Am J Nephrol; 2019; 49(1):32-40. PubMed ID: 30554209 [TBL] [Abstract][Full Text] [Related]
16. Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier. Boyarsky BJ; Strauss AT; Segev DL World J Surg; 2021 Dec; 45(12):3503-3510. PubMed ID: 33471156 [TBL] [Abstract][Full Text] [Related]
17. The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States: A National Registry Study. Durand CM; Bowring MG; Thomas AG; Kucirka LM; Massie AB; Cameron A; Desai NM; Sulkowski M; Segev DL Ann Intern Med; 2018 May; 168(10):702-711. PubMed ID: 29710288 [TBL] [Abstract][Full Text] [Related]
18. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety. Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164 [TBL] [Abstract][Full Text] [Related]
19. Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients. Sise ME; Chute DF; Gustafson JL; Wojciechowski D; Elias N; Chung RT; Williams WW Hemodial Int; 2018 Apr; 22 Suppl 1():S71-S80. PubMed ID: 29694722 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of viral hepatitis in solid organ transplantation]. Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]